One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-137742
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 6 |
Affiliation: Azienda Ospedaliero-Universitaria Careggi, University of Florence, Délégation Paris 7, Hôpital Saint-Louis, Université Paris Cité, Peking Union Medical College Hospital, Zhejiang University, West China Hospital of Sichuan University, Jiangsu Province Hospital, The University of Texas MD Anderson Cancer Center, Centre Hospitalier Universitaire d'Angers, Hôpital Lyon Sud, University of Perugia, Guy's and St Thomas' NHS Foundation Trust, Novartis (Switzerland), Erasmus MCThe Final Analysis of Expand: A Phase 1b, Open-Label, Dose-Finding Study of Ruxolitinib (RUX) in Patients (pts) with Myelofibrosis (MF) and Low Platelet (PLT) Count (50 × 109/L to < 100 × 109/L) at Baseline
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
